OOIR: Observatory of International Research

Papers

(The H4-Index of Clinical Microbiology and Infection is 80. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 500 papers]. The publications cover those that have been published in the past four years, i.e., from 2019-10-01 to 2023-10-01.)

Article	Citations
Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis	878
COVID-19, SARS and MERS: are they closely related?	722
Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study	509
Follow-up of adults with noncritical COVID-19 two months after symptom onset	438
Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting	436
Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review	434
Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis	430
Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China	412
Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study	404
Rapid and visual detection of 2019 novel coronavirus (SARS-CoV-2) by a reverse transcription loop-mediated isothermal amplification assay	398
Non-specific effects of BCG vaccine on viral infections	323
Clinical characteristics of asymptomatic and symptomatic patients with mild COVID-19	269
Novel SARS-CoV-2 variants: the pandemics within the pandemic	250
COVID-19 pandemic—a focused review for clinicians	247
SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analysis	243
COVID-19: don't neglect antimicrobial stewardship principles!	229
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society	224
BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in Israel	221
Saliva sample as a non-invasive specimen for the diagnosis of coronavirus disease 2019: a cross-sectional study	219
Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain	208
A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India	203
Field evaluation of a rapid antigen test (Panbio™ COVID-19 Ag Rapid Test Device) for COVID-19 diagnosis in primary healthcare centres	192
Diagnostic performance of seven rapid IgG/IgM antibody tests and the Euroimmun IgA/IgG ELISA in COVID-19 patients	191
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors	190
Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis	189

Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis	182
Impact of COVID-19 on maternal and neonatal outcomes: a systematic review and meta-analysis	178
European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults	177
Machine learning for clinical decision support in infectious diseases: a narrative review of current applications	166
Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients	165
Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: a retrospective study	164
Viable SARS-CoV-2 in various specimens from COVID-19 patients	163
Antibody response to SARS-CoV-2 mRNA vaccine among kidney transplant recipients: a prospective cohort study	160
Clinical characteristics of non-critically ill patients with novel coronavirus infection (COVID-19) in a Fangcang Hospital	155
Morbidity and mortality of candidaemia in Europe: an epidemiologic meta-analysis	145
Female gender is associated with long COVID syndrome: a prospective cohort study	142
Large-scale implementation of pooled RNA extraction and RT-PCR for SARS-CoV-2 detection	139
Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans	131
Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis	131
Recommendations for antibacterial therapy in adults with COVID-19 – an evidence based guideline	128
Diagnostic test accuracy of the BioFire® FilmArray® meningitis/encephalitis panel: a systematic review and meta-analysis	128
Validation of a commercially available SARS-CoV-2 serological immunoassay	126
Accuracy of a nucleocapsid protein antigen rapid test in the diagnosis of SARS-CoV-2 infection	126
Burden of bacterial bloodstream infection—a brief update on epidemiology and significance of multidrug-resistant pathogens	125
Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort study	125
Diagnostic strategies for SARS-CoV-2 infection and interpretation of microbiological results	117
Post–COVID-19 chronic symptoms: a postinfectious entity?	114
Severe acute respiratory syndrome coronavirus 2 RNA contamination of inanimate surfaces and virus viability in a health care emergency unit	112
Definitions for coronavirus disease 2019 reinfection, relapse and PCR re-positivity	111
Pathogenesis and management of fracture-related infection	110
Anosmia in COVID-19 patients	109
Antibody response against SARS-CoV-2 spike protein and nucleoprotein evaluated by four automated immunoassays and three ELISAs	108
Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1	107
Outbreak of Candida auris infection in a COVID-19 hospital in Mexico	101
Ibuprofen use and clinical outcomes in COVID-19 patients	99
How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST)	97
Evaluation of a rapid antigen test (Panbio™ COVID-19 Ag rapid test device) for SARS-CoV-2 detection in asymptomatic close contacts of COVID-19 patients	97
Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients—a multinational observational study by the European Confederation of Medical Mycology	96
Emergence of ceftazidime/avibactam resistance in carbapenem-resistant Klebsiella pneumoniae in China	96
Contaminating viral sequences in high-throughput sequencing viromics: a linkage study of 700 sequencing libraries	95
Antibody persistence in the first 6 months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal study	93
A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients	92
Detection and infectivity potential of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) environmental contamination in isolation units and quarantine facilities	92
Understanding the role of bacterial and fungal infection in COVID-19	90
Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review	90
Risk factors for disease progression in patients with mild to moderate coronavirus disease 2019—a multi-centre observational study	89
The role of asymptomatic and pre-symptomatic infection in SARS-CoV-2 transmission—a living systematic review	89
Association of COVID-19 with pregnancy outcomes in health-care workers and general women	88
Clinical evaluation of serological IgG antibody response on the Abbott Architect for established SARS-CoV-2 infection	88
2020 list of human papillomavirus assays suitable for primary cervical cancer screening	87
Antibody responses to BNT162b2 mRNA COVID-19 vaccine and their predictors among healthcare workers in a tertiary referral hospital in Japan	87
Quantitative SARS-CoV-2 anti-spike responses to Pfizer–BioNTech and Oxford–AstraZeneca vaccines by previous infection status	87
Cefepime neurotoxicity: thresholds and risk factors. A retrospective cohort study	86
Risk factors associated with COVID-19-associated pulmonary aspergillosis in ICU patients: a French multicentric retrospective cohort	85
Machine learning for microbial identification and antimicrobial susceptibility testing on MALDI-TOF mass spectra: a systematic review	84

Bloodstream infections – Standard and progress in pathogen diagnostics	84
Stigma at the time of the COVID-19 pandemic	84
Oral amoxicillin and amoxicillin–clavulanic acid: properties, indications and usage	82
Clinical course and factors associated with outcomes among 1904 patients hospitalized with COVID-19 in Germany: an observational study	82
Global prevalence of latent toxoplasmosis in pregnant women: a systematic review and meta-analysis	81
European all-cause excess and influenza-attributable mortality in the 2017/18 season: should the burden of influenza B be reconsidered?	80